The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
Bizimle İletişime Geçin
ERA Merkezi
- Mercati Cadde 16/A
- I-43126 Parma – İtalya
- Telefon: +39 0521 989078
- Faks: +39 0521 959242
ERA Kayıtlı Ofisi
- c/o PKF Littlejohn, 15 Westferry Circus,
- Canary Wharf
- London E14 4HD – Birleşik Krallık